Invesco Ltd. Celcuity Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.74 - $21.6 $190,876 - $300,067	-13,892 Reduced 6.64%	195,335 $4.22 Million
Q4 2023 Feb 12, 2024	BUY	$8.7 - $15.02 $1.82 Million - $3.14 Million	209,227 New	209,227 $3.05 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $24.87 $4.43 Million - $6.35 Million	-255,428 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$14.25 - $30.93 $3.64 Million - $7.9 Million	255,428 New	255,428 $6.13 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.